Shi and colleagues [41] discovered that following tumor vaccine administration, PD-1 is substantially expressed, and the PD-1/PD-L1 pathway remains open, suppressing T cell immunity and encouraging tumor escape. This evidence concerns the gene CD274 and neoplasm.